Absolute counts of lymphocytes and lymphocyte subsets in peripheral blood
Group . | Normal C57BL/6 (n = 15) . | Syngeneic full-term fetal blood (n = 5) . | Allogeneic T-cell–depleted bone marrow (n = 4) . | Allogeneic full-term fetal blood (n = 8) . |
---|---|---|---|---|
Total lymphocyte | 4243 ± 892 | 15 400 ± 3745* | 3051 ± 965 | 1534 ± 670*,†,‡ |
CD3+ | 1363 ± 241 | 2682 ± 345* | 1454 ± 516 | 931 ± 201*,†,‡ |
CD3+4+ | 773 ± 147 | 1540 ± 167* | 909 ± 274 | 605 ± 178*,†,‡ |
CD3+8+ | 379 ± 69 | 1140 ± 198* | 488 ± 254 | 305 ± 104† |
CD4+CD62L+ | 380 ± 57 | 433 ± 87 | 442 ± 132 | 146 ± 57*,†,‡ |
CD8+CD62L+ | 187 ± 144 | 182 ± 113 | 112 ± 41 | 76 ± 56† |
B220+ | 2912 ± 714 | 14 424 ± 4657* | 2352 ± 410 | 1024 ± 848*,†,‡ |
NK1.1+CD3− | 152 ± 44 | 164 ± 69 | 43 ± 10 | 56 ± 21*,† |
Group . | Normal C57BL/6 (n = 15) . | Syngeneic full-term fetal blood (n = 5) . | Allogeneic T-cell–depleted bone marrow (n = 4) . | Allogeneic full-term fetal blood (n = 8) . |
---|---|---|---|---|
Total lymphocyte | 4243 ± 892 | 15 400 ± 3745* | 3051 ± 965 | 1534 ± 670*,†,‡ |
CD3+ | 1363 ± 241 | 2682 ± 345* | 1454 ± 516 | 931 ± 201*,†,‡ |
CD3+4+ | 773 ± 147 | 1540 ± 167* | 909 ± 274 | 605 ± 178*,†,‡ |
CD3+8+ | 379 ± 69 | 1140 ± 198* | 488 ± 254 | 305 ± 104† |
CD4+CD62L+ | 380 ± 57 | 433 ± 87 | 442 ± 132 | 146 ± 57*,†,‡ |
CD8+CD62L+ | 187 ± 144 | 182 ± 113 | 112 ± 41 | 76 ± 56† |
B220+ | 2912 ± 714 | 14 424 ± 4657* | 2352 ± 410 | 1024 ± 848*,†,‡ |
NK1.1+CD3− | 152 ± 44 | 164 ± 69 | 43 ± 10 | 56 ± 21*,† |
Peripheral blood was obtained 200 days after transplantation and analyzed by flow cytometric analysis. The values represent absolute counts per μL blood (mean ± SD), which were obtained by using Flow-Count fluorospheres (Coulter, Miami, FL).
P < .05, compared with normal C57BL/6 mice.
P < .05, compared with syngeneic full-term fetal blood recipients (C57BL/6 → C57BL/6).
P < .05, compared with allogeneic T-cell–depleted bone marrow recipients.